Development of a Paediatric Physiologically Based Pharmacokinetic Model to Assess the Impact of Drug-Drug Interactions in Tuberculosis Co-Infected Malaria Subjects: A Case Study With Artemether-Lumefantrine and the CYP3A4-inducer Rifampicin
European Journal of Pharmaceutical Sciences - Netherlands
doi 10.1016/j.ejps.2017.05.043
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2017
Authors
Publisher
Elsevier BV